Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Çѱ¹Àο¡¼­ Àü¸³¼±¾ÏÀ» ¿¹ÃøÇÏ´Â µ¥ ÀÖ¾î Prostate Health Index DensityÀÇ ÀÓ»óÀû À¯¿ë¼º¿¡ °üÇÑ ÀüÇâÀû, ´Ù±â°ü ¿¬±¸ Potential Utility of Prostate Health Index Density for Prostate Cancer Detection and Prediction in Korean Men: A Prospective Multicenter Study

Journal of Urologic Oncology 2020³â 18±Ç 2È£ p.147 ~ 154
¼Û±âÇö, ¹ÚÈ«ÁÖ, ÀÌ»ó¿í, °­Å¿í, Á¤ÀçÈï, Á¤Çöö, ±è¼ºÁø, ¹ÚÁ¾¿¬, ±èÁ¤Çö,
¼Ò¼Ó »ó¼¼Á¤º¸
¼Û±âÇö ( Song Gee-Hyun ) 
Kangwon National University School of Medicine Department of Urology

¹ÚÈ«ÁÖ ( Park Hong-Zoo ) 
Kangwon National University School of Medicine Department of Urology
ÀÌ»ó¿í ( Lee Sang-Wook ) 
Kangwon National University School of Medicine Department of Urology
°­Å¿í ( Kang Tae-Wook ) 
Yonsei University Wonju College of Medicine Wonju Christian Hospital Department of Urology
Á¤ÀçÈï ( Jung Jae-Hung ) 
Yonsei University Wonju College of Medicine Wonju Christian Hospital Department of Urology
Á¤Çöö ( Chung Hyun-Chul ) 
Yonsei University Wonju College of Medicine Wonju Christian Hospital Department of Urology
±è¼ºÁø ( Kim Sung-Jin ) 
University of Ulsan College of Medicine Gangneung Asan Hospital Department of Urology
¹ÚÁ¾¿¬ ( Park Jong-Yeon ) 
University of Ulsan College of Medicine Gangneung Asan Hospital Department of Urology
±èÁ¤Çö ( Kim Jeong-Hyun ) 
Kangwon National University School of Medicine Department of Urology

Abstract


Purpose: We evaluated the clinical performance of Prostate Health Index (PHI) density with [-2]proPSA (p2PSA) and its derivatives in predicting the presence of prostate cancer (PCa) in Korean men.

Materials and Methods: A total of 706 men with total prostate-specific antigen (tPSA)¡Ã2.5 ng/mL who underwent their first prostate biopsy were included in this prospective, multicenter, observational study. Diagnostic accuracy of tPSA, free-to-total PSA ratio (%fPSA), p2PSA, %p2PSA, the Beckman Coulter PHI, and PHI density was assessed by receiver operating characteristic curve analyses and logistic regression analyses. PHI was calculated as [(p2PSA/free PSA)¡¿tPSA¨ö], and density calculations were performed using prostate volume as determined by transrectal ultrasonography.

Results: Overall, PCa was detected in 367 of all subjects (52%). In men with tPSA 2.5?10 ng/mL, the detection rate of PCa was 41.1% (188 of 457). In this group, PHI and PHI density were the most accurate predictors of PCa and significantly outperformed tPSA and %fPSA; area under the curve for tPSA, %fPSA, %p2PSA, PHI, and PHI density was 0.58, 0.68, 0.70, 0.75, 0.73 respectively. PHI and PHI density were also the strongest predictor of PCa with Gleason score ¡Ã7.

Conclusions: Based on the present prospective multicenter experience, PHI and PHI density demonstrate the superior clinical performance in predicting the presence of PCa in Korean men with tPSA 2.5?10 ng/mL.

Å°¿öµå

Biomarkers; Biopsy; Early diagnosis;; Prostatic cancer; Prostate-specific antigen; Protein isoforms

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI